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tial thromboplastin time, thrombin time, electrolytes and
liver function tests. Addition of a quantitative urine culture
and blood culture would be desirable for the detection and
treatment of concurrent bacteriuria and/or septicaemia.
This was evident in the above six patients who were diag-
nosed with UTI and prescribed appropriate antimicrobials.
Obviously, constant surveillance for any concurrent UTI in
dengue patients would be useful for therapeutic measures
against otherwise missed UTI.
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The role of mathematical modelling in malaria
elimination and eradication (Comment on: Can
malaria be eliminated?)
For many countries, as Professor Greenwood points out,
the answer to his question is a resounding ‘yes’.1 Perhaps
the more pertinent question is, with so many more inter-
ventions now available, ‘how?’. The two most important
new tools that have been added to our malaria control
arsenal since the 1950s are artemisinin combination thera-
pies and insecticide-treated bed nets. These are most likely
to be effective when used together, in combination with643
ndoor residual spraying where there are suitable vectors.
he problem we are faced with is a lack of experience of
sing such an elimination strategy on a large scale, lead-
ng to a lack of data, particularly on the best way to roll
ut ACTs. In the past, mass screening and treatment, mass
rug administration and large-scale replacement of ﬁrst-line
herapies have all been attempted, with varying degrees of
uccess. In the context of newly arisen artemisinin resis-
ance and the diminishing effectiveness of the pyrethroid
nsecticides, particular care must be taken to preserve the
ffectiveness of these compounds for as long as possible,
hilst achieving maximum impact in a wide variety of epi-
emiological settings.
Another powerful tool that we did not have in the
950s is sophisticated computer-based mathematical mod-
lling. This facilitates the use of the limited data currently
vailable to make predictions about future events. In
ther words, it provides a rational framework on which
o base decisions made using limited but diverse and
omplex inter-related information, such as population
emographics, pharmacokinetics and pharmacodynamics,
reatment-seeking behaviour, spatially distributed risk
actors, the presence of antimalarial resistance, etc. Iden-
ifying, preparing and calibrating such data sets for each
ountry for the application of mathematical models is a
uge challenge in itself.2 The accuracy of modelling pre-
ictions improves in an iterative process as more data
ecome available. Hence, the more intense the malaria
limination efforts are and as long as data are rigorously col-
ected, the more useful and informative modelling becomes.
he Bill and Melinda Gates Foundation and others have
ealized the potential of mathematical modelling to help
uide malaria elimination and eradication. Malaria elimina-
ion/eradication modelling is still in its infancy (a PubMed
earch for mathematical modelling papers with the key-
ords ‘malaria’, ‘elimination’ or ‘eradication’ produced
nly two articles)3,4 so these groups have provided signiﬁ-
ant funding to focus modelling efforts on this problem.
Professor Greenwood states that new tools are likely
o be required in order to eliminate malaria in high-
ransmission areas.1 If, eventually, we do have the luxury
f an effective malaria vaccine or powerful new gameto-
ytocidal drugs they are likely to be expensive and their
cale-up will inevitably be based on limited trial data in the
nitial stages. Mathematical modelling will be indispensible
n helping to maximize their impact.
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